Delivery Order SPE2DB24D9238-SPE2DB25FDRAE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,540.68 to DMS Pharmaceutical Group Inc. for the supply of EYLEA 2 mg/0.05 mL vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, is for pharmaceutical products to be delivered to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as the prime...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19,812.70 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order covers the supply of EYLEA HD 8 mg/0.07 mL vials, a prescription pharmaceutical product, with an ultimate completion date of October 6, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to...
- The Defense Logistics Agency awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml syringes. The contract, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of EYLEA 2 mg/0.05 ml vials totaling $25,135.40. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on July 30, 2025, is scheduled for ultimate completion by August 20, 2025, with performance taking place in Park Ridge, Illinois. The contract carries no set-aside designation, allowing DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $5,027.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml vials. The contract, with an ultimate completion date of September 25, 2025, was issued without set-aside designation, allowing DMS to compete on its merits as a small business in the federal pharmaceutical marketplace. This delivery order falls under DMS...
- The Defense Logistics Agency awarded a $2,513.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Eylea 2 mg/0.05 ml vials. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a specialized pharmaceutical procurement under DLA's broader pharmaceutical supply mission. This award carries no set-aside designation,...
- On August 12, 2025, the Defense Logistics Agency awarded a delivery order valued at $5,943.78 to DMS Pharmaceutical Group Inc. for the supply of EYLEA HD 8 mg/0.07 ml vials. This firm fixed-price delivery order, issued without a set-aside designation, is scheduled for completion by September 3, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime contractor and sole awardee on...
- The Defense Logistics Agency (DLA) awarded a $79.25K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 ml vials. The delivery order, issued on July 15, 2025, with an ultimate completion date of August 5, 2025, was awarded without a set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,940.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which has a completion date of July 18, 2024, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product used to treat certain medical conditions. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRAEDelivery Order
The Defense Logistics Agency (DLA) awarded a $11,887.62 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 mL vials. The award was issued on September 5, 2025, with an ultimate completion date of September 26, 2025. This delivery order carries no set-aside designation, allowing the vendor to compete on a competitive basis. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and deliver the pharmaceutical product to support military and federal healthcare system requirements. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialized medications and pharmacy services to Department of Defense healthcare facilities worldwide. EYLEA HD is a therapeutic ophthalmic medication used in treating eye diseases, reflecting the vendor's extensive portfolio covering oncology treatments, specialty pharmaceuticals, and various medical products supporting military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 9/5/25 |